Engineering of HEK293T Cell Factory for Lentiviral Production by High-Throughput Selected Genes
The CRISPR Journal · 2024
DOI: 10.1089/crispr.2024.0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The CRISPR Journal, 2024. Verfasst von Zhang Xinyue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin University of Science and Technology, Tianjin, China. Hauptthemen laut MEDLINE: Lentivirus, CRISPR-Cas Systems, Genetic Vectors, Gene Knockout Techniques. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Tianjin University of Science and Technology, Tianjin, China.
- Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
- Binzhou Medical University, Shandong, China.
- Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Bi Changhao
Zitieren
APA
Xinyue, Z., Li, S., Yujie, W., Yingcai, D., Changhao, B., & Xueli, Z. (2024). Engineering of HEK293T Cell Factory for Lentiviral Production by High-Throughput Selected Genes. The CRISPR Journal. https://doi.org/10.1089/crispr.2024.0016
Vancouver
Xinyue Z, Li S, Yujie W, Yingcai D, Changhao B, Xueli Z. Engineering of HEK293T Cell Factory for Lentiviral Production by High-Throughput Selected Genes. The CRISPR Journal. 2024. doi:10.1089/crispr.2024.0016
BibTeX
@article{Xinyue2024,
author = {Xinyue, Zhang and Li, Siwei and Yujie, Wang and Yingcai, Dai and Changhao, Bi and Xueli, Zhang},
title = {Engineering of HEK293T Cell Factory for Lentiviral Production by High-Throughput Selected Genes},
journal = {The CRISPR Journal},
year = {2024},
doi = {10.1089/crispr.2024.0016}
}
EUVIMED